Dr Solange Peters talks with ecancer about ETOP's current projects, including three new clinical trials, as well as updates on three The immunotherapy NSCLC revolution
Statement Solange Peters on EURTAC, OPTIMAL and SAKK 19/05 Chair, David P. Carbone, MD, PhD, Julie R. Brahmer, MD, MSc, Prof. Solange Peters, MD, PhD, and Boris Sepesi, MD, discuss
Prof. Solange Peters on Five Strategies to Extend Survival in Oncogene-driven NSCLC Curriculum Vitae – Solange PETERS, MD-PhD
Solange Peters, MD, PhD from the University of Lausanne, Lausanne, Switzerland discusses the latest data from the Phase II The European Oncology Nursing Society (EONS) conference is at the European Society for Medical Oncology (ESMO) Congress Data update in advanced stage NSCLC
Solange Peters, MD, Lausanne University Hospital, Switzerland On-site Interpretation of the DAREON-8 Study – The Bispecific Solange Peters, CHUV Lausanne: Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer (Faculty
Increasing patient access to the latest treatments Solange Peters, MD, PhD, is full professor and chair of medical oncology as well as the thoracic malignancies programme in the department of oncology.
The role of immunotherapy in the radical treatment of NSCLC: where are we headed? Solange Peters (Professor of Medical Oncology and President of ESMO): The Way forward for Oncology across Europe: Prof. Solange Peters, full professor, Chair of medical oncology and the thoracic malignancies programme, Department of
Solange Peters, MD, PhD, reporting from the ASCO Annual Meeting 2012, Chicago Solange Peters, MD, PhD from the University of Lausanne, Lausanne, Switzerland discusses the current treatment landscape of Interview with Solange Peters, Lausanne Subject: SAKK 19/05, OPTIMAL and EURTAC.
Prof. Fang Wu and Prof. Solange Peters Explore Future Pathways for Oncogene - Driven NSCLC Survival. Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 Solange Peters, MD, PhD, University Hospital Vaudois, Lausanne, Switzerland, explains how the Women for Oncology (W4O)
How a Never-Wavering Enthusiasm Changed Lung Cancer Care for Solange Peters, MD, PhD of Lausanne University Hospital, Lausanne, Switzerland kicks-off the first press conference at ESMO
Highlights from WCLC 2011, Panel with Dr Solange Peters, Lausanne and Prof Rolf A Stahel, Zurich. IASLC Leader Elected President of ESMO for 2020–2021: Solange
Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy Explore the new frontiers in oncology with a focus on advanced diagnostics and therapeutics. In this video, Dr. Solange Peters
Diary of an oncology leader: Episode 1 – Solange Peters Solange Peters, MD, PhD, University Hospital Vaudois, Lausanne, Switzerland, discusses how immunotherapies are a revolution
Interview with Prof Solange Peters (Lausanne, Switzerland) EONS at ESMO: the importance of nursing and integrated care in oncology
ESMO Congress 2021: Prof. Solange Peters on what is special about the congress ESMO is the leading professional organisation for medical oncology, and the annual ESMO Congress attracts thousands of
Recorded Tuesday August 9th @ WCLC 2022, Vienna. Comprehensive Cancer Center Zürich: Third Zurich Immuno-Oncology Symposium Developments in biomarkers and
Solange Peters, ESMO 2014 Press Officer, Lausanne, Switzerland Prof Solange Peters:
ESMO Congress 2021: Prof. Solange Peters on what is special about the congress. Produced by the European Society for 1 Day - Welcome Lecture. Highlights from WCLC 2011 with Dr Solange Peters, Lausanne and Prof Rolf A Stahel, Zurich
Peters Solange. Chair Medical Oncology @CHUV Lausanne Full Professor Lausanne University; ESMO President 2020-22. CHUV | Lausanne university hospital #women4onco with Solange Peters
Solange Peters vision and perspectives on ESMO Women for Oncology Solange Peters" Immune Checkpoint Inhibitor combinations" Challenges and opportunities for patients with advanced NSCLC
Dr. Peters on Creating Algorithms for Personalized Immunotherapy in NSCLC Solange Peters (@peters_solange) / Posts / X Solange Peters, MD, PhD from the University of Lausanne, Lausanne, Switzerland discusses the challenges and opportunities in
L'invité de la rédaction - Solange Peters ESMO President- Elect Solange Peters, MD, PhD, is head of the medical oncology service and chair of thoracic oncology in the Oncology Department. Cancer Center Zürich and Thoracic Oncology Center: Symposium Thoracic Oncology – Guidelines and Beyond - Friday January
itw solange peters ESMO 2014, Madrid 26 - 30 September 2014 Opening press conference Friday September 26: Solange Peters, ESMO 2014
In the first episode of Diary of an oncology leader, Solange Peters, Full professor and Chair of medical oncology at CHUV in New Frontiers in Oncology: Advanced Diagnostics and Therapeutics | Dr. Solange Peters Curriculum Vitae – Solange PETERS, MD-PhD. Bugnon 46 – 1011 Lauanne CHUV | Switzerland | solange.peters@chuv.ch | +41 795560192. 1. 1. Education. 2002. Degree
conference Friday September 26: Solange Peters, ESMO 2014 Press Officer, Lausanne, Switzerland Cancer drug approvals: Are Striving for Consensus on the Management of ALK-Positive Lung Cancer
SWISS WHO'S WHO WOMEN AWARDS 2023 - SOLANGE PETERS Prof Solange Peters, Chair ESMO Press Committee: Overview of ESMO Press Programme.
Solange Peters, ESMO 2014 Press Officer Solange Peters | Milken Institute
ESMO 2016: From disease treatment to patient care Solange Peters, MD, PhD, from the University of Lausanne, Lausanne, Switzerland discusses the ongoing clinical trials
Peters Solange – Chair Medical Oncology @CHUV Lausanne Full Pre Solange Peters · Education et formation. Professeure ordinaire (UNIL): 2019. Professeure associée (UNIL): 2016. European Society for Medical Solange Peters & Rolf Stahel comment the European Lung Cancer Conference (ELCC) 2018 Highlights
Solange Peters, MD, PhD, is a full professor, and chair of medical oncology and the thoracic malignancies programme in the Department of Oncology at the Solange Peters, Chair of the ESMO W4O Task Force shares her vision and views on the ESMO W4O initiative.
Solange Peters: Lung Cancer Highlights from ESMO 2019 Solange Peters: Lung Cancer Highlights from ESMO 2019 Recorded Tuesday October 1 at ESMO 2019 More info: Interview with Prof. Solange Peters on the ESMO Plenaries 1 of 4
ESMO 2016: Press brief Q&A on topics discussed at this year's meeting Medical Oncology Chair @CHUVLausanne, @ETOP_eu, @myESMO, @IASLC, @Women4Oncology, ESMO 20-23 President. Views expressed here are my own.
MedJ at ESMO 2025- Solange Peters Solange Peters, MD, PhD, of University Hospital Center Vaudois and Lausanne University in Switzerland, discusses the rapid Solange Peters, MD, PhD, Multidisciplinary Oncology Center, Lausanne Cancer Center, Centre Hospitalier Universitaire
After many negative trial results for non-small cell lung cancer (NSCLC) therapies for some time, the field is now evolving in a very Lecture Solange Peters Answering to the question "What is the bravest thing we can do about cancer?" Solange Peters, ESMO President, reflects on the
Featuring a discussion on the management of ALK-positive lung cancer with Dr Ross Camidge, Dr Justin Gainor, Prof Solange OncoInfluencers to Follow on Social Media: Dr. Solange Peters Immunotherapy is an exciting area for lung cancer, with numerous possibilities and game-changing potential. Speaking from the
In this press brief Q&A from ESMO 2016, Andrés Cervantes, MD, PhD of University of Valencia, Valencia, Spain, Solange Peters, Today on World Cancer Day, ESMO joins UICC in thanking oncology professionals worldwide, for their work throughout the
Pre Solange Peters - Département d'oncologie clinique - CHUV Prof. Fang Wu, Chief Physician and Professor at The Second Xiangya Hospital of Central South University, China, a National Solange Peters, cheffe du service d'oncologie médicale du CHUV, s'exprime sur la première pierre d'Agora, navire amiral du
Paradigm-changing immunotherapy for advanced NSCLC: the PACIFIC and beyond The BIRCH trial data discussed by Dr Peters Solange Peters | ESMO
EMCTO 2013: European Thoracic Oncology Platform Solange Peters - Lugano, 21 giugno 2019 ESMO 2022丨Interview with Professor Solange Peters: Sharing the Latest Research Progress
Solange Peters, ESMO President, for World Cancer Day 2021 solange peters - Google Scholar Solange Peters, ESMO President, for World Cancer Day 2020
WCLC 2022 Highlights: Prof. Solange Peters, CHUV, Lausanne & President, European Society for Med Inside The Issue: Professor Solange Peters, MD, PhD As a female leader in a competitive oncology field, Solange Peters, MD, PhD, pushed through the barriers— climbed over them—and completely
Dr Solange Peters Talk Q & A Dear colleagues,Please enjoy this presentation by @peters_solange delivered at the Cologne Conference on #lungcancer
Unanswered questions on immunotherapy for lung cancer EAA Convention 05_2022: Solange Peters
Solange Peters, MD, PhD, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, debates the use of adjuvant ELCC 2025|Dr. Solange Peters: Bispecific Antibodies & T-Cell Engagers – Battling the Immune Desert Watch Prof. Solange Peters, MD, PhD, Mark M. Awad, MD, PhD, and Jonathan D. Spicer, MD, PhD, FRCS…
Developments in biomarkers and immune-oncology combinations – Solange Peters Dr. Peters is highly active on X/Twitter and LinkedIn, where she shares her extensive expertise in medical oncology, particularly focusing on thoracic